Read & Publish: Frequently asked questions
- Why has The Company of Biologists launched a Read & Publish Open Access initiative?
- What are Read & Publish agreements?
- How does Read & Publish pricing work?
- Are multi-year agreements available?
- Which libraries are participating in your Read & Publish initiative?
- Have agreements been signed with library consortia for Read & Publish agreements?
- Will The Company of Biologists deposit my manuscript in PubMed Central?
- What are the benefits of Read & Publish agreements for researchers and libraries?
- How has The Company of Biologists engaged with Open Access?
- Are Read & Publish agreements for the long term?
- Who do I contact to find out more?
Why has The Company of Biologists launched a Read & Publish Open Access initiative?
We are a not-for-profit publisher with a mission to support biologists and inspire biology. We have been committed to Open Access since 2004, as we believe immediate and free access to the latest research is important for the advancement of science. Our new Read & Publish agreements have considerable benefits for researchers and their institutions. Our initiative supports researchers in complying with funder mandates. Authors at participating institutions can publish Open Access articles in our subscription-based journals without having to pay Article Processing Charges (APCs). We now look forward to working with libraries and library consortia to accelerate a cost-neutral transition to Open Access, and to increase submissions and usage.
What are Read & Publish agreements?
Read & Publish agreements are an alternative to traditional subscriptions. Agreements between a publisher and institution have two components – a read fee and an Open Access fee.
How does Read & Publish pricing work?
Pricing is based on an institution’s current subscription spend (Read), plus the average Article Processing Charge (APC) spend over the prior 3 years (Publish).
A competitive read fee is offered to institutions that have not previously subscribed to our journals. This will include unlimited access to Development, Journal of Cell Science and Journal of Experimental Biology (including back files), plus unlimited fee-free publishing of Open Access articles.
For library consortia, we apply the same pricing structure, i.e. the member institutions’ previous year’s subscription spend (Read), plus the average Article Processing Charge (APC) spend over the prior 3 years (Publish). The total consortium price will depend on the number of institutions within the consortium wishing to participate in the agreement.
Are multi-year agreements available?
Yes. To gain maximum benefit from our Read & Publish deals, we would recommend a term of two to three years. Your multi-year agreements will include a capped annual increase for your protection.
Which libraries are participating in your Read & Publish initiative?
A list of participating libraries is available here.
Have agreements been signed with library consortia for Read & Publish agreements?
Yes, a list of participating consortia is available here.
Will The Company of Biologists deposit my manuscript in PubMed Central?
Yes. All articles published via Read & Publish will automatically be deposited in PubMed Central.
What are the benefits of Read & Publish agreements for researchers and libraries?
Read & Publish agreements benefit libraries, researchers and science.
- No fees or invoices.
- Unlimited publishing across our hybrid journals for all corresponding authors under CC-BY licence terms, with authors retaining copyright.
- Easy compliance with funders’ Open Access mandates.
- Automatic deposition to PubMed Central.
- Higher visibility of articles.
- Transparent pricing plus ease of administration with no Article Processing Charges (APCs) to manage.
- Unlimited access to Development, Journal of Cell Science and Journal of Experimental Biology including back files dating from 1853 – even if your library does not currently subscribe to them all.
- Open Access reporting as part of our workflow.
- Multi-year agreements with low renewal pricing.
How has The Company of Biologists engaged with Open Access?
We have actively engaged with the Open Access movement since 2004 because it helps us to deliver our mission to support biologists and inspire biology. Open Access publishing leads to broader dissemination and faster reuse, accelerating the sharing of quality information.
We publish two fully Open Access journals, Disease Models & Mechanisms and Biology Open. Both are indexed in DOAJ. Authors can publish Open Access in these titles, or they can publish Open Access in our subscription-based journals, under a CC_BY licence. We also deposit authors’ articles into PubMed Central.
Are Read & Publish agreements for the long term?
The Open Access landscape is changing fast, and it’s hard to predict what the future will bring. We have demonstrated our commitment to the Open Access movement since 2004, and we believe that our Read & Publish initiative has the potential to be a long-term, transformative solution that will work for us as a not-for-profit publisher as well as for our community.
Who do I contact to find out more?
If you have any questions about Read & Publish agreements, or if you would like a quote, please contact:
Richard Grove, Commercial Manager, email@example.com